70
X.-Y. DOU, L.-N. HE, AND Z.-Z. YANG
3-Butyl-5-phenyloxazolidin-2-one (2d). Colorless liquid. 1H NMR
(300 MHz, CDCl3): d 0.94 (t, J ¼ 7.2 Hz, 3H), 1.31–140 (m, 2H), 1.51–1.58 (m,
2H), 3.23–3.38 (m, 2H), 3.43 (t, J ¼ 8.0 Hz, 1H), 3.92 (t, J ¼ 8.8 Hz, 1H), 5.49 (t,
J ¼ 8.0 Hz, 1H), 7.28–7.42 (m, 5H). 13C NMR (75 MHz, CDCl3): d 13.4, 19.5,
29.1, 43.6, 51.8, 74.1, 125.2, 128.4,128.5, 138.7, 157.7. ESI-MS calcd. for
C13H17NO2 219.13; found 220.34 (M þ H)þ, 259.48 (MþK)þ, 461.05 (2M þ Na)þ.
3-Isopropyl-5-phenyloxazolidin-2-one (2e). Colorless liquid. 1H NMR
(300 MHz, CDCl3): d 1.16 (d, J ¼ 6.8 Hz, 3H), 1.22 (d, J ¼ 6.8 Hz, 3H), 3.37 (t,
J ¼ 8.0 Hz, 1H), 3.87 (t, J ¼ 8.8 Hz, 1H), 4.13–4.23 (m, 1H), 5.48 (t, J ¼ 8.0 Hz,
1H), 7.34–7.42 (m, 5H). 13C NMR (75 MHz, CDCl3): d 19.1, 19.6, 44.5, 47.0, 74.2,
125.1, 128.3, 128.5, 138.7,156.7. ESI-MS calcd. for C12H15NO2 205.11; found
206.29 (M þ H)þ, 433.08 (2M þ Na)þ.
3-Cyclopropyl-5-phenyloxazolidin-2-one
(2f). White
crystals;
mp
1
52–55 ꢀC. H NMR (300 MHz, CDCl3) d 0.75 (s, 4H), 2.55–2.59 (m, 1H), 3.43 (t,
J ¼ 8.1 Hz, 1H), 3.88 (t, J ¼ 8.7 Hz, 1H), 5.42 (t, J ¼ 8.1 Hz, 1H), 7.28–7.37 (m,
5H). 13C NMR (75 MHz, CDCl3) d 5.4, 5.8, 25.7, 53.3, 74.3, 125.4, 128.6, 128.7,
138.5, 157.9. ESI-MS calcd. for C12H13NO2 203.09; found 429.27 (2M þNa)þ,
631.80 (3M þ Na)þ.
3-Isobutyl-5-phenyloxazolidin-2-one (2g). White crystals; mp 38–42 ꢀC.
1H NMR (300 MHz, CDCl3): d 0.91 (d, J ¼ 4.8 Hz, 3H), 0.93 (d, J ¼ 4.8 Hz, 3H),
1.81–1.95 (m, 1H), 3.02–3.16 (m, 2H), 3.42 (dd, J ¼ 8.7 Hz, J ¼ 7.5 Hz, 1H), 3.91
(t, J ¼ 8.7 Hz, 1H),5.48 (t, J ¼ 8.4 Hz, 1H), 7.32–7.41 (m, 5H). 13C NMR (75 MHz,
CDCl3): d 19.7, 19.8,26.7, 51.6, 52.6, 74.1, 125.3, 128.5, 128.7, 138.8, 158.0. ESI-MS
calcd. for C13H17NO2 219.13; found 461.22 (2M þ Na)þ, 679.70 (3M þNa)þ.
HRMS: calcd. for C13H17NO2 (M þH)þ 220.1332; found 220.1339.
3-Isopentyl-5-phenyloxazolidin-2-one (2h). Colorless liquid. 1H NMR
(300 MHz, CDCl3): d 0.92 (d, J ¼ 3.3 Hz, 3H), 0.94 (d, J ¼ 3.3 Hz, 3H), 1.43 (q,
J ¼ 7.5 Hz, 2H), 1.54–1.65 (m, 1H), 3.22–3.36 (m, 2H), 3.41 (t, J ¼ 7.8 Hz, 1H),
3.91 (t, J ¼ 8.7 Hz, 1H), 5.46 (t, J ¼ 8.1 Hz, 1H), 7.33–7.39 (m, 5H). 13C NMR
(75 MHz, CDCl3): d 22.2, 22.3,25.6, 35.9, 42.4, 52.0, 74.2, 125.3, 128.6, 128.7,
138.8, 157.7. ESI-MS calcd. for C14H19NO2 233.14; found 489.17 (2M þ Na)þ,
721.97 (3M þ Na)þ. HRMS: calcd. for C14H19NO2 (M þ H)þ 234.1489; found
234.1489.
3-Ethyl-5-p-tolyloxazolidin-2-one (2i). White crystals; mp 49–53 ꢀC. 1H
NMR (300 MHz, CDCl3): d 1.18 (t, J ¼ 7.2 Hz, 3H), 2.36 (s, 3H), 3.29–3.45 (m,
3H), 3.89 (t, J ¼ 8.7 Hz, 1H), 5.45 (t, J ¼ 8.1 Hz, 1H), 7.19–7.24 (m, 4H). 13C
NMR (75 MHz, CDCl3): d12.6, 21.2, 38.9, 51.6, 74.4, 125.6, 129.5, 135.9, 138.7,
157.7. ESI-MS calcd. for C12H15NO2 205.11; found 206.15 (M þ H)þ, 433.92
(2M þ Na)þ.
5-(4-Chlorophenyl)-3-ethyloxazolidin-2-one (2j). White crystals; mp
1
73–77 ꢀC. H NMR (300 MHz, CDCl3): d 1.18 (t, J ¼ 15 Hz, 3H), 3.32–3.42 (m,
3H), 3.92 (t, J ¼ 9 Hz, 1H), 5.46 (t, J ¼ 6 Hz, 1H), 7.28–7.40 (m, 4H). 13C NMR
(75 MHz, CDCl3): d 12.5, 38.9,51.5, 73.5, 126.9, 129.1, 134.6, 137.4, 157.3, 162.3.
ESI-MS calcd. for C11H12NO2Cl 225.06; found 226.17 (M þ H)þ.